75 related articles for article (PubMed ID: 8319842)
1. Postprandial release of glucagon-like peptide-1, pancreatic glucagon, and insulin after esophageal resection.
Miholic J; Orskov C; Holst JJ; Kotzerke J; Pichlmayr R
Digestion; 1993; 54(2):73-8. PubMed ID: 8319842
[TBL] [Abstract][Full Text] [Related]
2. Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy.
Miholic J; Orskov C; Holst JJ; Kotzerke J; Meyer HJ
Dig Dis Sci; 1991 Oct; 36(10):1361-70. PubMed ID: 1914756
[TBL] [Abstract][Full Text] [Related]
3. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
[TBL] [Abstract][Full Text] [Related]
4. Effects of lipase inhibition on gastric emptying of, and on the glycaemic, insulin and cardiovascular responses to, a high-fat/carbohydrate meal in type 2 diabetes.
O'Donovan D; Horowitz M; Russo A; Feinle-Bisset C; Murolo N; Gentilcore D; Wishart JM; Morris HA; Jones KL
Diabetologia; 2004 Dec; 47(12):2208-14. PubMed ID: 15662558
[TBL] [Abstract][Full Text] [Related]
5. Involvement of endogenous glucagon-like peptide-1 in regulation of gastric motility and pancreatic endocrine secretion.
Witte AB; Grybäck P; Jacobsson H; Näslund E; Hellström PM; Holst JJ; Hilsted L; Schmidt PT
Scand J Gastroenterol; 2011 Apr; 46(4):428-35. PubMed ID: 21114428
[TBL] [Abstract][Full Text] [Related]
6. The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal.
Frost GS; Brynes AE; Dhillo WS; Bloom SR; McBurney MI
Eur J Clin Nutr; 2003 Feb; 57(2):293-8. PubMed ID: 12571662
[TBL] [Abstract][Full Text] [Related]
7. GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans.
Näslund E; Bogefors J; Skogar S; Grybäck P; Jacobsson H; Holst JJ; Hellström PM
Am J Physiol; 1999 Sep; 277(3):R910-6. PubMed ID: 10484511
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release.
Enç FY; Imeryüz N; Akin L; Turoğlu T; Dede F; Haklar G; Tekeşin N; Bekiroğlu N; Yeğen BC; Rehfeld JF; Holst JJ; Ulusoy NB
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G752-63. PubMed ID: 11518688
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes.
Todd JF; Edwards CM; Ghatei MA; Mather HM; Bloom SR
Clin Sci (Lond); 1998 Sep; 95(3):325-9. PubMed ID: 9730852
[TBL] [Abstract][Full Text] [Related]
10. The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans.
Meier JJ; Gethmann A; Nauck MA; Götze O; Schmitz F; Deacon CF; Gallwitz B; Schmidt WE; Holst JJ
Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1118-23. PubMed ID: 16403774
[TBL] [Abstract][Full Text] [Related]
11. Secretion of glucagon-like peptide-1 and reactive hypoglycemia after partial gastrectomy.
Andreasen JJ; Orskov C; Holst JJ
Digestion; 1994; 55(4):221-8. PubMed ID: 8063025
[TBL] [Abstract][Full Text] [Related]
12. Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses.
Little TJ; Pilichiewicz AN; Russo A; Phillips L; Jones KL; Nauck MA; Wishart J; Horowitz M; Feinle-Bisset C
J Clin Endocrinol Metab; 2006 May; 91(5):1916-23. PubMed ID: 16492694
[TBL] [Abstract][Full Text] [Related]
13. Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome.
Gebhard B; Holst JJ; Biegelmayer C; Miholic J
Dig Dis Sci; 2001 Sep; 46(9):1915-23. PubMed ID: 11575444
[TBL] [Abstract][Full Text] [Related]
14. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects.
Chaikomin R; Doran S; Jones KL; Feinle-Bisset C; O'Donovan D; Rayner CK; Horowitz M
Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E504-7. PubMed ID: 15886226
[TBL] [Abstract][Full Text] [Related]
15. Endogenous GLP-1 regulates postprandial glycemia in humans: relative contributions of insulin, glucagon, and gastric emptying.
Nicolaus M; Brödl J; Linke R; Woerle HJ; Göke B; Schirra J
J Clin Endocrinol Metab; 2011 Jan; 96(1):229-36. PubMed ID: 21047924
[TBL] [Abstract][Full Text] [Related]
16. Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation.
Kuo P; Stevens JE; Russo A; Maddox A; Wishart JM; Jones KL; Greville H; Hetzel D; Chapman I; Horowitz M; Rayner CK
J Clin Endocrinol Metab; 2011 May; 96(5):E851-5. PubMed ID: 21389144
[TBL] [Abstract][Full Text] [Related]
17. Relation between gastric emptying of glucose and plasma concentrations of glucagon-like peptide-1.
Wishart JM; Horowitz M; Morris HA; Jones KL; Nauck MA
Peptides; 1998; 19(6):1049-53. PubMed ID: 9700754
[TBL] [Abstract][Full Text] [Related]
18. Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion.
Salehi M; Vahl TP; D'Alessio DA
J Clin Endocrinol Metab; 2008 Dec; 93(12):4909-16. PubMed ID: 18827000
[TBL] [Abstract][Full Text] [Related]
19. Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes.
Meier JJ; Gallwitz B; Salmen S; Goetze O; Holst JJ; Schmidt WE; Nauck MA
J Clin Endocrinol Metab; 2003 Jun; 88(6):2719-25. PubMed ID: 12788879
[TBL] [Abstract][Full Text] [Related]
20. Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia.
Deane AM; Nguyen NQ; Stevens JE; Fraser RJ; Holloway RH; Besanko LK; Burgstad C; Jones KL; Chapman MJ; Rayner CK; Horowitz M
J Clin Endocrinol Metab; 2010 Jan; 95(1):215-21. PubMed ID: 19892837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]